Colorectal Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Colorectal Cancer Diagnostic Trends and Forecast

The future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030, and it is forecast to grow at a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Colorectal Cancer Diagnostic by Segment

The study includes a forecast for the global colorectal cancer diagnostic by product type, cancer type, age group, end use, and region.

Colorectal Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables & Accessories

Colorectal Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

• Adenocarcinoma
• Colorectal Lymphoma
• Gastrointestinal Stromal Tumors
• Carcinoid Tumors
• Others

Colorectal Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Geriatric
• Adults
• Pediatric

Colorectal Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Cancer Research Centers
• Ambulatory Surgical Centers
• Others

Colorectal Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colorectal Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer diagnostic companies profiled in this report include-

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Colorectal Cancer Diagnostic Market Insights

• Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.
• Within this market, diagnostic centers will remain the largest segment due to growing need for cost effective diagnosis facilities for colorectal cancer disease and rising number of diagnostic centers globally.
• North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Features of the Global Colorectal Cancer Diagnostic Market

• Market Size Estimates: Colorectal cancer diagnostic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Colorectal cancer diagnostic market size by various segments, such as by product type, cancer type, age group, end use, and region in terms of ($B).
• Regional Analysis: Colorectal cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, age groups, end uses, and regions for the colorectal cancer diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer diagnostic market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the colorectal cancer diagnostic market size?

Answer: The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030.

Q.2 What is the growth forecast for colorectal cancer diagnostic market?

Answer: The global colorectal cancer diagnostic market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the colorectal cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures and increasing healthcare expenditure.

Q4. What are the major segments for colorectal cancer diagnostic market?

Answer: The future of the colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.

Q5. Who are the key colorectal cancer diagnostic market companies?

Answer: Some of the key colorectal cancer diagnostic companies are as follows:

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Q6. Which colorectal cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Q7. In colorectal cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer diagnostic market by product type (instruments and consumables & accessories), cancer type (adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others), age group (geriatric, adults, and pediatric), end use (hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.